Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/30350
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChand A.L.en
dc.contributor.authorClyne C.D.en
dc.contributor.authorHerridge K.A.en
dc.contributor.authorHoward T.L.en
dc.contributor.authorSimpson E.R.en
dc.date.accessioned2021-05-14T10:15:36Zen
dc.date.available2021-05-14T10:15:36Zen
dc.date.copyright2011en
dc.date.created20110622en
dc.date.issued2012-10-04en
dc.identifier.citationSteroids. 76 (8) (pp 741-744), 2011. Date of Publication: July 2011.en
dc.identifier.issn0039-128Xen
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/30350en
dc.description.abstractIn postmenopausal breast cancers, the increase in aromatase expression observed in tumour associated adipose stromal cells is mediated via the upregulation of promoter II (PII) transcription. Factors such as PGE2 which are secreted from breast carcinomas induce PII expression. The orphan nuclear receptor LRH-1/NR5A2 is one of the critical downstream transcriptional mediators of this effect. The aim of the current study was to determine whether LRH-1 could bind directly to PII and whether the suppression of LRH-1 expression could inhibit aromatase expression in human adipose stromal fibroblasts. Chromatin immunoprecipitation demonstrated endogenous LRH-1 occupancy on PII under basal conditions and with treatment with forskolin and phorbol 12-myristate 13-acetate (PMA). To assess the impact of LRH-1 knockdown on FSK/PMA mediated PII expression, cells were transfected with shRNA targeted against LRH-1 (shLRH-1) and treated with forskolin and PMA. A decrease in LRH-1, PII and total aromatase mRNA transcripts was observed in shLRH-1 transfected cells compared to controls under basal and treatment conditions. The results of this study support the hypothesis that suppression of LRH-1 may potentially be beneficial in the tissue specific regulation of aromatase expression in post menopausal breast cancer. © 2011 Elsevier Inc. All rights reserved.en
dc.languageEnglishen
dc.languageenen
dc.publisherElsevier Inc. (360 Park Avenue South, New York NY 10010, United States)en
dc.titleTissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts.en
dc.typeConference Paperen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.steroids.2011.02.024en
dc.identifier.pubmedid21392518 [http://www.ncbi.nlm.nih.gov/pubmed/?term=21392518]en
dc.identifier.source51335231en
dc.identifier.institution(Chand, Herridge, Howard, Simpson, Clyne) Prince Henry's Institute, Monash Medical Centre, 246 Clayton Road, Melbourne, VIC 3168, Australiaen
dc.description.addressA. L. Chand, Prince Henry's Institute, Monash Medical Centre, 246 Clayton Road, Melbourne, VIC 3168, Australia. E-mail: ashwini.chand@princehenrys.orgen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2012 Elsevier B.V., All rights reserved.en
dc.subect.keywordsAromatase Breast cancer LRH-1 NR5A2en
dc.identifier.authoremailChand A.L.; ashwini.chand@princehenrys.orgen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeConference Paper-
Appears in Collections:Conferences
Show simple item record

Page view(s)

4
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.